» Authors » Fabrizio Guarracini

Fabrizio Guarracini

Explore the profile of Fabrizio Guarracini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 372
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gigli L, Preda A, Testoni A, Kotinas A, Tacchetto A, Guarracini F, et al.
Front Cardiovasc Med . 2025 Mar; 12:1552340. PMID: 40041171
Background: wide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrial fibrillation (PAF), although time-demanding. We investigated the impact of a standardized ablation protocol by using a bidirectional...
2.
Preda A, Melillo F, Baroni M, Marzi A, Schillaci V, Vargiu S, et al.
Pacing Clin Electrophysiol . 2025 Feb; PMID: 39913112
Background: The need for transvenous lead extraction (TLE) is increasing worldwide. Since the course of the subclavian vein until the junction with the superior vena cava is a frequent place...
3.
Falco R, Baroni M, Gigli L, Guarracini F, Carbonaro M, Colombo G, et al.
G Ital Cardiol (Rome) . 2025 Feb; 26(2):100-105. PMID: 39898740
The extravascular implantable cardioverter-defibrillator (EV-ICD, Aurora, Medtronic, Minneapolis, MN, USA) has recently been validated as a new device for preventing arrhythmic death with the aim of reducing vascular and mechanical...
4.
Tognola C, Ruzzenenti G, Maloberti A, Varrenti M, Mazzone P, Giannattasio C, et al.
Diagnostics (Basel) . 2025 Jan; 15(2. PMID: 39857023
Anderson-Fabry disease (AFD) is a rare X-linked lysosomal storage disorder characterized by the accumulation of globotriaosylceramide, leading to multi-organ involvement and significant morbidity. Cardiovascular manifestations, particularly arrhythmias, are common and...
5.
Taormina A, Grossi B, Ragaini E, Falasconi G, Penela D, Ceriotti C, et al.
J Clin Med . 2025 Jan; 14(1. PMID: 39797213
Pulmonary vein isolation (PVI) represents the cornerstone of paroxysmal (PAF) and persistent atrial fibrillation (PsAF) ablation. Impedance values provide insights on tissue conductive properties. Consecutive patients undergoing PAF and PsAF...
6.
Gigli L, Preda A, Coluzzi D, Sartore M, Vila M, Carbonaro M, et al.
Front Physiol . 2024 Dec; 15:1474568. PMID: 39665050
Background: Electrical remodeling has been linked to the progression and recurrence of atrial fibrillation (AF) after catheter ablation (CA). Substrate mapping based solely on a voltage amplitude electrogram (EGM) does...
7.
Preda A, Falasconi G, Melillo F, Margonato D, Posteraro G, Vella C, et al.
Int J Cardiol . 2024 Dec; 421():132875. PMID: 39645044
Background: Patients with non-valvular atrial fibrillation (nvAF) who experienced a cardioembolic (CE) event despite adequate oral anticoagulation (OAC) are at high risk of recurrence and the combination between percutaneous left...
8.
Bonanni M, Frazzetto M, Nardone A, Meucci F, Musto C, Quaranta G, et al.
Front Cardiovasc Med . 2024 Aug; 11:1419018. PMID: 39139754
Introduction: Recent studies have shown gender differences in cardiovascular outcomes after left atrial appendage closure (LAAC), highlighting different complication rates and adverse events, particularly in short-term assessments. As a result,...
9.
Valcher S, Villaschi A, Falasconi G, Chiarito M, Giunti F, Novelli L, et al.
J Clin Med . 2024 Aug; 13(15). PMID: 39124807
Low-voltage area (LVA) ablation, in addition to pulmonary vein isolation (PVI), has been proposed as a new strategy in patients with atrial fibrillation (AF), but clinical trials have shown conflicting...
10.
Guarracini F, Martin M, Marini M, Branzoli S, Casagranda G, Muser D, et al.
Rev Cardiovasc Med . 2024 Jul; 23(5):155. PMID: 39077597
Several studies in literature have shown that 90% of emboli related to non-valvular atrial fibrillation originate from left atrial appendage. Percutaneous closure or surgical exclusion of left atrial appendage in...